FIELD: medicine.
SUBSTANCE: endothelial dysfunction is induced in experimental Wistar male rats for 28 days by daily intraperitoneal introduction of N-nitro-L-arginine methyl ester 12.5 mg/kg a day. An agent for dysfunction correction is a mixture of solutions of homoeopathic dilutions of interleukin-6 antibodies - C12, C30, C200; it is introduced at the same time for 28 day intragastrically 2 times a day in a dose of 4.5 ml/kg.
EFFECT: method provides effective endothelial dysfunction correction.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF INTERLEUKIN-1 ANTIBODIES | 2011 |
|
RU2526150C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE ANTIBODIES | 2011 |
|
RU2477529C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODIES | 2011 |
|
RU2526151C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE ANTIBODIES IN COMPLEX WITH SOLUTION OF HOMOEOPATHIC DILUTIONS OF ANGIOTENSIN II RECEPTOR C-TERMINAL FRAGMENT ANTIBODIES | 2011 |
|
RU2500425C2 |
| METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF ANGIOTENSIN II RECEPTOR C-TERMINAL FRAGMENT ANTIBODIES | 2011 |
|
RU2482546C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF TUMOUR NECROSIS FACTOR ALPHA ANTIBODIES | 2011 |
|
RU2478233C2 |
| MEDICATION FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2536228C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2541166C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2526149C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543331C2 |
